Abrdn Life Sciences Investors (HQL)

NYSE: HQL · Real-Time Price · USD

19.48

+0.07 (0.36%)

Sep 21, 2026, 11:45 AM EDT - Market open

HQL Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Income	198.17	85.59	-	-	-	-
Loss (Gain) From Sale of Investments	-202.92	-88.97	-	-	-	-
Other Operating Activities	44.56	35.29	-	-	-	-
Change in Accounts Receivable	-0.01	0.06	-	-	-	-
Change in Other Net Operating Assets	0.02	-0.26	-	-	-	-
Operating Cash Flow	39.81	31.71	-	-	-	-
Operating Cash Flow Growth	-	-	-	-	-	-

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Common Dividends Paid	-33.28	-31.63	-	-	-	-
Financing Cash Flow	-39.81	-31.63	-	-	-	-

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Cash Flow	-0	0.08	-	-	-	-

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Levered Free Cash Flow	-4.35	-2.18	-	-	-	-
Unlevered Free Cash Flow	-4.35	-2.18	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Change in Working Capital	0.01	-0.2	-	-	-	-

SEC Filings: 10-K · 10-Q